biolog
membran
repres
one
import
interfac
cellular
system
serv
physic
barrier
regul
signal
transduct
pathway
play
key
role
cellular
protect
homeostasi
beyond
direct
function
membran
also
scaffold
upon
protein
associ
stabil
cellular
structur
promot
adhes
direct
transport
process
among
function
one
measur
membran
interfac
biomed
import
around
approv
drug
target
membraneassoci
protein
addit
mani
viral
pathogen
take
advantag
membran
part
life
cycl
specif
membran
serv
platform
viral
protein
bind
host
cell
well
organ
complex
catalyz
critic
synthesi
activ
viral
genom
replic
given
event
take
place
membran
interfac
mani
possibl
therapeut
intervent
target
diseaserel
process
abnorm
signal
viral
membran
fusion
inflammatori
cascad
beyond
wide
rang
membraneassoci
process
amen
molecular
target
also
multipl
strategi
one
target
exampl
ion
channel
embed
lipid
membran
may
either
stimul
inhibit
electr
forc
mechan
forc
chemic
cue
therapeut
possibl
includ
target
lipid
membran
modul
physic
properti
includ
permeabl
well
disrupt
enzymat
activ
membraneassoci
protein
interact
macromolecul
compon
regardless
biomed
problem
necessari
understand
fundament
molecular
mechan
target
interact
continu
progress
develop
biolog
tool
led
major
advanc
determin
structur
function
biolog
macromolecul
biophys
method
nuclear
magnet
reson
nmr
electron
paramagnet
reson
epr
spectroscopi
enabl
structur
character
protein
membraneassoci
state
inform
significantli
improv
fundament
understand
relationship
membraneassoci
protein
well
aid
identif
new
therapeut
target
howev
date
major
challeng
monitor
dynam
membraneprotein
interact
well
interact
enzymat
process
membran
interfac
overcom
challeng
common
tactic
design
solubl
form
analyt
protein
studi
directli
solut
presenc
membranemimick
compon
deterg
although
enzymat
activ
recombin
protein
typic
monitor
inform
gain
interact
protein
host
membran
environ
interact
affect
function
step
membran
associ
may
target
amount
inform
gain
target
interact
limit
use
nonn
system
engin
strategi
offer
promis
approach
studi
interfaci
scienc
principl
membraneassoci
biolog
activ
physiolog
relev
set
central
theme
engin
scienc
fundament
character
model
biolog
system
defin
necessari
paramet
systemat
evalu
consequ
approach
help
understand
selfassembl
function
activ
biolog
system
easili
chang
paramet
facilit
character
work
model
system
often
studi
surfacesensit
analyt
tool
rang
techniqu
exist
probe
biolog
thin
film
interfac
measur
acoust
optic
spectroscop
electr
chemic
morpholog
properti
wealth
option
mani
analyt
strategi
choos
order
character
specif
target
interact
regardless
character
method
import
design
appropri
model
system
mimic
import
structur
properti
target
interact
importantli
studi
membraneassoci
biolog
process
model
membran
enjoy
advantag
selfassembl
format
permit
facil
adjust
system
paramet
bottomup
design
enabl
develop
model
membran
system
probe
wide
rang
biolog
process
cell
adhes
membran
fusion
cellular
signal
mani
excel
review
alreadi
field
howev
limit
demonstr
thu
far
knowledg
gain
approach
translat
clinic
impact
biomed
applic
review
articl
establish
framework
demonstr
engin
strategi
leverag
sens
advantag
model
membran
system
yield
novel
therapi
pois
enter
drug
pipelin
solv
challeng
biomed
problem
one
seriou
global
health
problem
urgent
need
combat
infecti
diseas
emerg
new
infecti
diseas
well
reemerg
other
number
socioeconom
evolutionari
environment
molecular
biolog
issu
hinder
develop
effect
diagnost
therapeut
option
inde
one
biggest
hurdl
need
identifi
new
molecular
target
order
counter
emerg
drugresist
pathogen
case
studi
exampl
viral
pathogen
target
select
hepat
c
viru
hcv
discuss
engin
strategi
identifi
previous
unknown
function
activ
encod
within
hcv
nonstructur
protein
employ
model
membran
platform
mimic
host
cell
membran
interfac
upon
viral
genom
replic
occur
strike
abil
lyse
lipid
vesicl
discov
within
ntermin
amphipath
ah
lipid
vesicl
also
serv
simplifi
model
lipid
envelop
viru
particl
mechanist
studi
predict
rang
medic
import
virus
might
suscept
ruptur
treatment
synthet
ah
peptid
importantli
predict
test
valid
molecular
virolog
experi
demonstr
ah
peptid
broadspectrum
antivir
activ
hcv
hiv
herp
simplex
viru
dengu
viru
well
mani
deadli
pathogen
ah
peptid
repres
first
class
lipid
enveloperuptur
antivir
agent
beyond
identif
one
drug
candid
studi
also
led
develop
new
test
platform
rapidli
character
antivir
drug
candid
minut
taken
togeth
model
membran
technolog
demonstr
signific
potenti
biomedicin
yield
new
biotechnolog
clinic
applic
solv
rang
import
biomed
problem
throughout
histori
impact
infecti
diseas
human
societi
stagger
reach
across
numer
sector
includ
economi
sociolog
healthcar
polit
educ
present
approxim
million
annual
death
world
direct
result
infecti
diseas
fig
within
number
sever
class
diseas
individu
caus
death
hundr
thousand
even
million
peopl
per
year
fig
sever
million
death
occur
year
complic
chronic
infect
despit
advanc
treatment
option
signific
work
remain
toward
erad
infecti
diseas
thu
far
princip
antivir
therapeut
strategi
vaccin
strategi
proven
effect
erad
viral
pathogen
polio
smallpox
vaccin
develop
sever
import
viral
diseas
includ
respiratori
tract
virus
human
papilloma
virus
herp
virus
haemorrhag
fever
virus
unsuccess
moreov
vaccin
avail
influenza
viru
type
b
hepat
b
viru
effect
treatment
requir
addit
antivir
drug
still
prone
emerg
viral
resist
well
variabl
toler
efficaci
notabl
promis
vaccin
pipelin
either
hcv
hiv
nonetheless
viral
pathogen
two
deadliest
million
peopl
worldwid
infect
hiv
astound
million
peopl
infect
hcv
given
largescal
impact
viral
pathogen
select
hcv
prototyp
case
demonstr
model
membran
offer
platform
target
membraneassoci
step
viru
life
cycl
order
catalyz
develop
power
antivir
drug
hcv
member
flavivirida
famili
contain
hepaciviru
flaviviru
pestiviru
genera
divers
virus
within
classic
swine
fever
viral
enceph
also
import
common
featur
small
lipidenvelop
rna
virus
mani
analog
step
viral
life
cycl
includ
host
cell
entri
viral
polyprotein
process
viral
genom
replic
inde
similar
flavivirida
member
hcv
posit
singlestrand
rna
viru
kb
genom
encod
acid
long
polyprotein
fig
upon
translat
host
cell
machineri
nascent
polyprotein
process
cellular
viral
proteas
produc
two
class
matur
protein
structur
compon
matur
viron
nonstructur
ns
protein
play
import
role
viral
genom
replic
fig
replic
hcv
genom
errorpron
process
creat
genom
divers
hinder
effect
treatment
hcv
infect
target
ns
protein
mediat
replic
attract
pharmaceut
strategi
halt
hcv
infect
wide
rang
ns
protein
summari
properti
includ
membran
associ
function
statu
drug
target
present
tabl
like
positivestrand
rna
virus
hcv
genom
replic
occur
close
associ
host
cellderiv
membran
particularli
endoplasm
reticulum
er
genom
replic
virus
occur
surfac
preexist
vesicular
membran
virus
includ
hcv
promot
format
de
novo
membran
structur
hcv
ns
protein
interact
togeth
membran
platform
term
membran
web
form
replicas
multiprotein
complex
direct
rna
polymeras
activ
inhibitor
proteas
polymeras
enter
latestag
clinic
trial
see
tabl
alreadi
becom
clear
addit
target
hcv
replicas
need
identifi
minim
effect
viral
resist
success
clinic
treatment
therefor
major
area
research
molecular
virolog
hcv
identif
new
target
pharmacolog
inhibit
recent
year
signific
focu
direct
hcv
protein
protein
implic
regul
host
cell
protein
activ
modul
viru
sensit
interferon
treatment
known
enzymat
function
nevertheless
key
compon
hcv
replicas
complex
necessari
viral
replic
given
hcv
replicas
activ
occur
membran
interfac
interest
possess
ntermin
amphipath
ah
necessari
proper
cytoplasm
membran
local
host
cell
inde
genet
mutat
analysi
confirm
ah
necessari
hcv
replic
togeth
necess
ah
membran
associ
viral
genom
replic
suggest
target
membran
associ
would
repres
prime
therapeut
target
inhibit
replic
compar
hcv
target
prone
viral
resist
ah
possess
signific
sequenc
homolog
across
hcv
isol
identifi
date
thu
amphipath
membraneassoci
properti
conserv
function
target
design
model
system
investig
membran
associ
ah
might
lead
viabl
inhibit
strategi
shown
fig
repres
model
present
membran
associ
domain
contain
ntermin
ah
domain
propos
associ
lipid
membran
dimer
nmr
studi
deterg
system
shown
ah
region
interact
lipid
membran
monotyp
fashion
ah
partial
insert
membran
parallel
orient
follow
structur
character
work
increas
focu
develop
method
studi
bind
kinet
ah
membran
associ
regard
model
membran
platform
offer
sever
uniqu
advantag
model
membran
simplifi
version
cellular
membran
base
lipid
bilay
assembl
biolog
studi
design
emphasi
mimick
fundament
properti
membran
includ
bilay
environ
fluiditi
order
success
host
membraneassoci
motif
two
main
type
model
membran
intact
vesicl
platform
fig
planar
lipid
bilay
fig
although
consist
lipid
materi
physic
properti
planar
bilay
intact
vesicl
platform
quit
differ
planar
bilay
present
flat
uniform
surfac
lipid
compon
exhibit
longrang
twodimension
later
diffus
selfassembl
certain
substrat
mica
silicon
oxid
surfaceinduc
vesicl
fusion
adsorpt
subsequ
ruptur
lipid
vesicl
reach
critic
vesicl
concentr
substrat
importantli
platform
intim
associ
support
substrat
collect
featur
two
effect
first
planar
bilay
rigidli
coupl
substrat
therefor
thin
hydrat
layer
exist
substrat
lower
leaflet
second
surfac
pressur
bilay
increas
peripher
membran
protein
phospholipas
adsorb
partial
insert
lipid
membran
rise
surfac
pressur
termin
macromolecul
adsorpt
lower
bind
satur
valu
model
biolog
system
contrast
intact
vesicl
platform
compris
adsorb
unruptur
lipid
vesicl
spheric
lipid
vesicl
adsorb
substrat
gold
titanium
oxid
deform
ruptur
result
layer
pancakelik
vesicl
whose
morpholog
nonuniform
intrins
curvatur
platform
surfac
import
detect
curvaturesensit
bind
protein
contain
bar
domain
intact
vesicl
contain
hydrodynam
coupl
solvent
encapsul
within
inner
core
therefor
layer
viscoelast
properti
result
layer
soft
film
respons
bind
amphipath
macromolecul
specif
vesicl
modul
physic
properti
order
maintain
constant
surfac
pressur
cours
bind
interact
flexibl
enabl
determin
bind
satur
valu
repres
biolog
system
addit
model
membran
sens
platform
consist
cellderiv
membran
contain
natur
assort
compon
includ
lipid
protein
glycosaminoglycan
model
membran
repres
gener
platform
studi
membran
associ
process
driven
amphiphil
interact
cellderiv
membran
contain
receptor
mediat
specif
bind
protein
studi
conjunct
model
cellderiv
membran
identifi
determin
membran
associ
target
protein
inde
approach
significantli
aid
character
bind
dynam
ah
one
recent
studi
monitor
membraneprotein
interact
work
quartz
crystal
microbal
dissip
monitor
qcmd
techniqu
select
qcmd
enabl
realtim
monitor
bind
kinet
chang
thin
film
properti
therefor
becom
increasingli
popular
probe
biolog
interfac
model
membran
platform
first
assembl
sensor
chip
monitor
membran
associ
ah
peptid
model
membran
studi
planar
bilay
selfassembl
silicon
oxid
fig
b
expect
ah
peptid
demonstr
bind
planar
lipid
bilay
fig
wherea
control
nh
peptid
bind
fig
experi
good
agreement
past
biolog
result
thu
establish
correl
standard
molecular
virolog
techniqu
qcmd
technolog
bind
peptid
protein
model
membran
demonstr
studi
follow
initi
experi
develop
novel
biomembraneonachip
platform
cellderiv
membran
human
liver
tumor
cell
line
commonli
use
hcv
replic
assembl
sensor
chip
platform
probe
bind
ah
peptid
case
significantli
ah
peptid
associ
cellderiv
membran
compar
planar
bilay
fig
howev
nh
peptid
bind
cellderiv
platform
fig
comparison
studi
model
cellderiv
membran
suggest
specif
bind
receptor
ah
within
cellderiv
membran
confirm
bind
specif
author
combin
biochem
method
qcmd
platform
specif
pretreat
trypsin
remov
proteinac
compon
cell
membran
experi
interact
ah
peptid
transactiv
transcript
tat
deriv
peptid
trypsintr
membran
monitor
tatderiv
peptid
demonstr
bind
fig
bind
mass
valu
calcul
qcmd
result
confirm
tatderiv
peptid
show
posit
bind
mass
treat
membran
platform
fig
discrep
expect
tatderiv
peptid
believ
bind
membran
via
extracellular
glycosaminoglycan
protein
receptor
contrast
sensit
ah
peptid
bind
trypsin
treatment
support
specif
interact
protein
receptor
addit
experi
one
set
control
perform
verifi
remov
proteinac
compon
trypsin
treatment
protein
tyrosin
phosphatas
membran
protein
found
membran
absenc
trypsin
treatment
antibodi
bind
observ
fig
howev
trypsin
treatment
bind
occur
fig
verifi
trypsin
treatment
valid
method
remov
proteinac
compon
assay
format
qcmd
monitor
enabl
sensit
detect
membranepeptid
interact
draw
conclus
result
studi
requir
integr
analysi
biochem
properti
biomembraneonachip
platform
base
collect
set
experi
ah
peptid
demonstr
significantli
greater
bind
cellderiv
versu
model
membran
batteri
biochem
control
experi
confirm
differ
caus
proteinac
compon
found
cellderiv
membran
combin
model
cellderiv
membran
platform
author
abl
support
confirm
hypothesi
protein
receptor
ah
resid
membran
host
cell
endoplasm
reticulum
character
interact
ah
peptid
intact
vesicl
platform
qcmd
monitor
atom
forc
microscopi
afm
employ
complementari
techniqu
respect
probe
interact
kinet
morpholog
chang
adsorpt
lipid
vesicl
onto
solid
support
result
selfassembl
differ
lipid
structur
shown
previou
exampl
lipid
vesicl
adsorb
ruptur
silicon
oxid
form
planar
bilay
contrast
lipid
vesicl
adsorb
ruptur
gold
instead
intact
vesicl
form
stabl
layer
qcmd
measur
demonstr
selfassembl
process
follow
exponenti
adsorpt
kinet
result
format
stabl
sens
platform
fig
strikingli
upon
addit
ah
peptid
vesicl
platform
intact
vesicl
layer
transform
planar
bilay
fig
control
experi
nh
peptid
demonstr
amphipath
charact
ah
peptid
key
determin
vesicleruptur
abil
fig
structur
transform
process
also
follow
directli
afm
imag
order
measur
height
profil
bare
gold
surfac
fig
intact
vesicl
layer
fig
planar
bilay
fig
analysi
confirm
format
planar
bilay
gold
vesicl
ruptur
typic
membran
lysi
process
catalyz
peptid
result
particularli
excit
first
exampl
biolog
interact
promot
structur
transform
viscoelast
layer
form
nonviscoelast
film
contrast
earlier
exampl
identifi
hook
et
al
demonstr
structur
transform
mussel
adhes
protein
adlay
process
induc
chemic
reaction
crosslink
protein
film
case
ah
peptid
direct
biolog
relev
membran
associ
ah
necessari
hcv
genom
replic
critic
strategi
also
solv
major
design
challeng
fabric
planar
bilay
gold
number
attract
electr
optic
properti
anoth
studi
ah
peptidemedi
process
vesicl
ruptur
planar
bilay
format
fit
voigtvoinova
base
model
analyz
peptid
interact
alter
film
properti
includ
thick
effect
shear
modulu
shear
viscos
fit
model
qcmd
reson
frequenc
energi
dissip
measur
ah
peptidemedi
structur
transform
record
multipl
overton
fig
h
film
thick
calcul
voigtvoinova
model
confirm
sauerbrey
describ
simpl
linear
relationship
chang
reson
frequenc
mass
adsorpt
limit
valid
analyz
rigid
film
soft
layer
fig
result
model
confirm
import
collect
wide
rang
data
case
addit
inform
enabl
chang
mechan
properti
thin
film
correl
ah
peptidemembran
interact
combin
approach
may
also
help
studi
mechan
ah
peptid
vesicleruptur
activ
base
result
studi
observ
sever
key
find
first
maximum
bind
signal
gener
adsorpt
ah
peptid
intact
vesicl
platform
significantli
greater
signal
planar
bilay
platform
part
discrep
may
due
differ
structur
featur
planar
bilay
versu
layer
intact
vesicl
inde
fix
geometri
intact
vesicl
would
avail
surfac
area
peptid
bind
planar
bilay
howev
bind
signal
normal
account
vari
amount
lipid
materi
differ
platform
bind
signal
intact
vesicl
platform
still
time
greater
depend
target
interact
platform
design
issu
may
import
consider
biosens
second
interact
kinet
complet
distinct
case
planar
bilay
platform
simpl
exponenti
adsorpt
kinet
observ
minim
peptid
bind
behavior
suggest
interact
nonspecif
mediat
amphipath
natur
peptid
membraneassoci
ah
peptid
exist
monomer
state
contrast
interact
ah
peptid
intact
vesicl
promot
structur
transform
intact
vesicl
layer
planar
bilay
interact
kinet
complex
show
twostep
process
voigtvoinova
model
help
determin
effect
transform
process
film
properti
addit
evid
necessari
understand
mechan
process
regard
recent
work
hatzaki
et
al
intrins
properti
bilay
recruit
larger
densiti
amphipath
molecul
highli
curv
deserv
attent
addit
intact
vesicl
layer
biolog
relev
model
membran
system
interact
kinet
observ
system
may
relat
role
protein
hcv
life
cycl
third
concentrationdepend
ah
peptid
interact
vari
platform
concentr
mgml
ah
peptid
transform
layer
intact
vesicl
planar
bilay
howev
concentr
ah
peptid
bind
planar
bilay
higher
concentr
ah
peptid
necessari
detect
bind
signal
planar
bilay
platform
taken
togeth
qcmd
respons
data
support
transform
intact
vesicl
layer
titanium
oxid
gold
result
format
complet
planar
bilay
compar
sens
properti
planar
bilay
prototyp
silicon
oxid
substrat
applic
standpoint
fabric
planar
bilay
formerli
intract
substrat
advantag
design
optic
electrochemicalbas
sensor
assembl
planar
bilay
gold
titanium
oxid
repres
import
step
toward
applic
biolog
tool
solv
problem
materi
scienc
complet
descript
fundament
mechan
behind
transform
process
requir
detail
studi
multipl
angl
order
evalu
biomed
signific
inde
complex
biolog
phenomena
difficult
interpret
base
singl
physic
principl
case
interact
ah
peptid
lipid
vesicl
qcmd
energi
dissip
signal
associ
vesicletobilay
transform
indic
intermedi
regim
high
viscoelast
chang
film
viscoelast
might
occur
due
increas
bound
solvent
result
vesicl
swell
exampl
howev
qcmd
techniqu
sens
acoust
mass
combin
mass
adsorb
materi
eg
lipid
andor
amino
acid
well
bound
solvent
basi
measur
alon
possibl
identifi
solvent
mass
fraction
chang
transform
address
challeng
therefor
import
character
biointerfaci
process
use
sever
surfacesensit
techniqu
measur
differ
physic
principl
investig
mechan
ah
peptid
modul
film
properti
intact
vesicl
layer
simultan
qcmd
reflectometri
measur
follow
ah
peptidemedi
vesicletobilay
transform
gold
report
acoust
wavebas
qcmd
techniqu
character
structur
properti
adlay
film
opticalbas
reflectometri
techniqu
provid
measur
bound
molecular
mass
relat
effect
thick
effect
refract
index
adlay
two
techniqu
combin
sever
paramet
simultan
measur
function
time
includ
adsorb
molecular
mass
optic
mass
adsorb
molecular
mass
solvent
mass
acoust
mass
effect
film
thick
effect
refract
index
cours
time
result
solvent
mass
calcul
separ
acoust
optic
mass
vesicl
swell
expans
initi
hypothes
caus
ah
peptidemedi
vesicl
ruptur
process
abil
follow
chang
solvent
mass
particularli
import
test
hypothesi
understand
biolog
mechan
base
combin
measur
approach
vesicletobilay
structur
transform
process
follow
qcmd
reson
frequenc
fig
energi
dissip
signal
fig
reflectometri
signal
simultan
record
surfac
fig
use
number
formal
qcmd
reflectometri
data
convert
acoust
optic
mass
term
describ
physic
properti
adsorb
film
chang
acoust
optic
solvent
mass
film
follow
function
time
fig
analysi
identifi
four
regim
describ
transform
process
soft
intact
vesicl
layer
initi
interact
ah
peptid
vesicl
layer
vesicl
ruptur
rigid
planar
bilay
magnifi
view
fig
present
highlight
sever
key
observ
regim
initi
peptid
interact
vesicl
ruptur
fig
first
select
surfacesensit
techniqu
critic
detect
target
interact
minor
structur
chang
detect
qcmd
techniqu
upon
initi
bind
ah
peptid
contrast
reflectometri
abl
clearli
identifi
quantifi
bind
step
second
satur
ah
peptid
bind
occur
swell
vesicl
reach
satur
lag
time
approxim
min
suggest
membran
associ
ah
peptid
insuffici
directli
caus
swell
vesicl
destabil
rather
type
peptid
rearrang
eg
pore
format
may
occur
induc
solvent
uptak
third
optic
mass
measur
provid
direct
evid
ah
peptid
bind
lipid
vesicl
anoth
benefit
combin
measur
approach
abil
calcul
hydrat
signatur
describ
role
solvent
mass
throughout
cours
interact
demonstr
paramet
use
compar
macromolecular
interact
selfassembl
process
planar
bilay
format
silicon
oxid
gold
compar
fig
especi
use
featur
hydrat
signatur
direct
identif
individu
kinet
step
describ
overal
mechan
biolog
interact
taken
togeth
combin
qcmd
reflectometri
techniqu
enabl
complet
descript
ah
peptidemedi
vesicl
ruptur
process
larg
increas
adsorb
mass
energi
dissip
caus
swell
vesicl
upon
interact
ah
peptid
base
kinet
differ
optic
acoust
mass
respons
appear
bind
ah
peptid
necessari
suffici
promot
structur
transform
instead
ah
peptid
presum
rearrang
membran
interfac
promot
vesicl
swell
destabil
lead
reassembl
planar
bilay
format
mechanist
detail
reveal
framework
place
evalu
biomed
signific
interact
engin
optim
peptid
potent
ruptur
activ
determin
ah
peptid
possess
suitabl
properti
ruptur
lipid
envelop
viru
particl
necessari
develop
appropri
model
system
mimic
envelop
structur
sens
intact
lipid
vesicl
excel
choic
replic
membran
environ
lipid
envelop
unlik
planar
bilay
intact
vesicl
also
recapitul
membran
curvatur
mechan
ah
peptid
vesicl
ruptur
activ
alreadi
determin
combin
qcmd
reflectometri
measur
determin
situ
vesicl
ruptur
activ
may
correl
vitro
viru
particl
ruptur
initi
studi
ah
peptidemedi
ruptur
process
focus
vesicl
nm
diamet
size
rang
select
zwitterion
lipid
vesicl
diamet
easili
ruptur
silicon
oxid
fundament
character
surfacespecif
adsorpt
kinet
vesicl
size
therefor
fix
variabl
paramet
substrat
materi
character
work
eventu
led
develop
planar
bilay
intact
vesicl
platform
use
probe
ah
peptidemedi
vesicl
ruptur
gener
differ
film
properti
two
platform
suffici
studi
membran
properti
affect
interact
howev
evalu
ah
peptid
intact
vesicl
platform
modifi
better
mimic
properti
lipidenvelop
viru
particl
one
key
differ
particl
differ
virus
size
distribut
therefor
use
paramet
studi
inde
one
studi
recent
use
intact
vesicl
platform
qcmd
assay
determin
vesicl
size
rang
within
ah
peptid
demonstr
ruptur
activ
order
evalu
virus
ah
peptid
may
target
qcmd
measur
identifi
three
regim
describ
process
ah
peptidemedi
vesicl
ruptur
complet
planar
bilay
format
vesicl
averag
diamet
less
nm
incomplet
ruptur
vesicl
averag
diamet
greater
nm
minim
ruptur
vesicl
diamet
significantli
larger
nm
fig
b
base
result
evalu
criterion
degre
vesicl
ruptur
establish
assess
ruptur
activ
ah
peptid
lipid
vesicl
vari
size
fig
ruptur
percentag
provid
gener
quantit
framework
measur
perform
candid
antivir
target
lipid
envelop
well
ident
compound
abrog
ah
peptid
activ
larger
vesicl
averag
diamet
least
nm
bind
mass
ah
peptid
vesicl
layer
calcul
sauerbrey
relationship
fig
size
rang
predomin
interact
ah
peptid
bind
rather
vesicl
ruptur
taken
togeth
data
demonstr
ah
peptid
possess
select
target
small
viru
particl
base
result
graph
construct
identifi
sever
flavivirida
member
includ
hcv
like
target
ah
peptid
fig
atom
forc
microscopi
afm
measur
confirm
ah
peptid
treatment
physic
disrupt
lipid
envelop
virus
includ
hcv
within
target
size
rang
fusion
peptid
deriv
viral
envelop
protein
previous
shown
display
antivir
activ
either
destabil
lipid
envelop
interf
fusogen
domain
envelop
protein
ah
peptid
neither
involv
membran
fusion
known
interact
protein
domain
within
hcv
protein
furthermor
protein
nonstructur
protein
involv
intracellular
hcv
genom
replic
part
hcv
virion
sever
antimicrobi
peptid
also
describ
physic
disrupt
viral
envelop
directli
monitor
physic
effect
ah
peptid
treatment
envelop
virus
well
confirm
find
viral
replic
monitor
studi
demonstr
intact
vesicl
platform
repres
reliabl
model
system
predict
suscept
individu
virus
ah
peptid
treatment
predict
valid
virus
close
approxim
key
properti
synthet
lipid
vesicl
includ
lipid
envelop
minim
heterogen
particl
size
furthermor
like
size
correspond
vesicl
ruptur
maximum
size
ah
peptid
ruptur
viru
particl
probabl
case
ruptur
abil
ah
peptid
viru
particl
occur
continuum
observ
fig
therefor
ah
peptid
may
greater
observ
effect
smaller
viru
particl
like
still
interact
larger
particl
may
affect
infect
even
absenc
direct
ruptur
addit
method
focus
determin
biophys
mechan
ah
peptidemedi
vesicl
ruptur
process
order
predict
therapeut
effect
group
follow
confirm
vitro
activ
ah
peptid
molecular
virolog
approach
screen
hcvderiv
peptid
capabl
inhibit
hcv
viral
entri
cheng
et
al
serendipit
discov
ah
peptid
virocid
activ
peptid
ntermin
ah
anchor
strongest
effect
inhibit
hcv
infect
fig
clarif
note
peptid
amino
acid
fragment
full
amino
acid
long
ntermin
ah
peptid
team
origin
describ
detail
analysi
reveal
inhibit
hcv
infect
submicromolar
noncytotox
concentr
fig
find
import
certain
antimicrobi
peptid
dermaseptin
tachyplesin
display
inhibitori
activ
envelop
virus
albeit
broadspectrum
antivir
develop
limit
result
cytotox
issu
compar
daili
treatment
recombin
human
interferonalpha
standard
hcv
treatment
option
inhibit
intracellular
hcv
rna
accumul
almost
effect
day
fig
importantli
outperform
day
treatment
suggest
peptid
halt
persist
hcv
infect
growtharrest
cell
anoth
import
featur
identifi
author
peptid
penetr
cell
membran
fig
intracellular
virocid
activ
fig
notabl
chang
amount
intracellular
hcv
rna
confirm
find
ah
peptid
directli
ruptur
hcv
particl
one
point
note
report
cheng
et
al
peptid
extracellular
virocid
activ
effici
intracellular
activ
bioavail
peptid
therapeut
inde
gener
challeng
effect
drug
concentr
reach
intracellular
target
may
ultim
direct
peptid
extracellular
applic
prophylaxi
nonetheless
vivo
studi
mice
support
peptid
promis
toxic
profil
nonimmunogen
addit
target
hcv
addit
infect
assay
demonstr
ah
peptid
broadspectrum
activ
hiv
addit
member
flavivirida
lipidenvelop
viru
particl
importantli
shown
tabl
molecular
virolog
result
support
mechan
action
identifi
base
engin
strategi
particular
ah
peptid
directli
target
lipidenvelop
viru
particl
within
certain
size
rang
inde
virus
target
ah
peptid
averag
particl
size
diamet
near
vesicl
ruptur
valu
measur
qcmd
assay
contrast
ah
peptid
effect
viru
particl
without
lipid
envelop
whose
particl
size
diamet
much
larger
ruptur
valu
notabl
virus
includ
influenza
viru
borna
diseas
viru
possess
lipid
envelop
particl
size
diamet
near
ruptur
valu
yet
suscept
treatment
ah
peptid
work
need
fulli
elucid
molecular
determin
viru
suscept
mani
suscept
virus
hcv
west
nile
viru
dengu
viru
bud
endoplasm
reticulum
er
membran
cheng
et
al
attempt
explain
result
propos
verifi
ah
peptid
target
membran
certain
lipid
composit
contrast
model
provid
conclus
evid
critic
paramet
viru
inhibit
size
lipidenvelop
particl
nonetheless
composit
lipid
envelop
may
secondari
factor
could
easili
test
model
membran
platform
summari
recent
virolog
studi
confirm
situ
character
ah
peptid
vesicl
ruptur
activ
reliabl
predictor
vitro
virocid
activ
lipidenvelop
viru
particl
key
paramet
ah
peptid
virocid
activ
found
amphipath
sequenc
necessari
lone
cystein
residu
also
necessari
may
involv
disulfid
bond
format
variat
amino
acid
composit
peptid
differ
hcv
genotyp
correl
vari
level
virocid
activ
term
optim
adjust
ah
peptid
sequenc
composit
therefor
use
modul
antivir
potenc
therapeut
index
inde
li
et
al
recent
describ
ration
design
secondgener
peptid
preserv
potent
antihcv
antihiv
activ
minim
hemolyt
activ
collect
result
achiev
thu
far
demonstr
potenti
engin
strategi
character
target
membraneassoci
step
viral
life
cycl
applic
model
membran
platform
target
hcv
protein
led
discoveri
broadspectrum
antivir
activ
exhibit
ah
peptid
part
process
fundament
character
ah
peptidemembran
interact
yield
set
estim
ah
peptid
virocid
activ
includ
size
rang
lipidenvelop
viru
particl
may
target
activ
valid
molecular
virolog
studi
ah
peptid
drug
pipelin
outlook
introduc
area
envis
engin
strategi
may
aid
antivir
drug
develop
assembl
situ
assay
predict
viru
particl
ruptur
work
review
establish
costeffect
tool
rapidli
screen
function
character
antivir
drug
candid
minut
rather
day
base
preliminari
format
system
improv
increas
sensit
reduc
amount
peptid
materi
requir
andor
adapt
signal
respons
readili
highthroughput
measur
techniqu
one
altern
assay
possibl
multipl
studi
report
ah
peptid
ruptur
membran
lipid
vesicl
observ
releas
encapsul
fluoresc
dye
howev
assay
would
first
need
standard
function
character
screen
thu
far
report
describ
assay
use
differ
lipid
composit
fluoresc
dye
reagent
concentr
thereof
vesicl
prepar
method
vari
physic
character
vesicl
properti
paramet
would
affect
measur
respons
need
control
consider
rais
awar
challeng
studi
biointerfaci
scienc
demonstr
engin
strategi
describ
streamlin
drug
develop
increas
reproduc
accuraci
signific
benefit
establish
qcmd
vesicl
ruptur
assay
abil
directli
character
physic
properti
intact
vesicl
platform
method
major
differ
film
properti
identifi
experi
minor
differ
normal
realtim
monitor
interact
kinet
yield
distinct
complex
signatur
base
selfassembl
process
difficult
gener
fals
posit
due
complex
signatur
yet
also
still
practic
screen
signatur
highthroughput
format
lead
clear
result
selfassembl
planar
bilay
gold
wellcharacter
mass
viscoelast
properti
present
known
would
correl
result
qcmd
assay
fluorescencebas
membran
ruptur
assay
nonetheless
continu
innov
type
function
assay
help
speed
drug
discoveri
develop
one
area
engin
assay
would
use
character
class
antivir
drug
candid
beyond
lipid
enveloperuptur
peptid
small
molecul
compound
report
physic
disrupt
lipid
membran
interestingli
compound
display
gener
properti
membran
disrupt
perman
damag
membran
virus
host
cell
unlik
host
cell
maintain
biogen
capac
repair
lipid
membran
virus
repar
capac
result
compound
low
toxic
profil
chemic
structur
amen
optim
improv
pharmacokinet
along
new
class
phospholipidmimick
rafi
rigid
amphipath
fusion
inhibitor
broadspectrum
small
molecul
antivir
avail
russia
china
biophys
mechan
fusion
inhibitor
remain
determin
term
look
forward
also
believ
ah
repres
uniqu
target
addit
zincbind
domain
ntermin
ah
sole
valid
function
target
promis
result
recent
phase
clinic
trial
compound
hcv
infect
patient
follow
oncedaili
dose
regimen
huge
potenti
develop
addit
inhibit
strategi
protein
inde
amphipath
charact
ah
conserv
across
hcv
isol
date
make
ah
far
less
like
evolv
resist
mutat
qcmd
vesicl
ruptur
assay
could
altern
use
screen
chemic
librari
small
molecul
inhibit
vesicl
ruptur
ah
peptid
token
broadspectrum
antivir
activ
ah
peptid
attract
mani
therapeut
use
includ
broadspectrum
antivir
agent
even
immun
adjuv
summari
engin
strategi
offer
new
approach
probe
biolog
system
design
physiolog
relev
model
platform
bottomup
design
focu
antivir
drug
develop
model
membran
offer
excel
platform
studi
wide
rang
membraneassoci
biolog
process
sinc
mani
activ
critic
determin
human
health
excit
wit
applic
strategi
solv
biomed
problem
current
intract
